Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hifzur R Siddique

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Cell death discovery

Drug and chemical toxicology

Epigenomics

Phytotherapy research : PTR

Aligarh Muslim University

CSIR-Indian Institute of Toxicology Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aligarh Muslim University

India

Senior Assistant Professor

Education History

CSIR-Indian Institute of Toxicology Research Jan 28o 2003 - Feb 14o 2008

India

PHD :: Embryo Toxicology

Publications

Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Unveiling the therapeutic promise of natural products in alleviating drug-induced liver injury: Present advancements and future prospects. Phytotherapy research : PTR (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements. Epigenomics (2023)
Da-Wei Yeh, Xuyao Zhao, Hifzur R Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M Tahara, Douglas E Feldman, Lin Chen, Keigo Machida
MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery 9 (1) (2023)
Mohd Jameel, Homa Fatma, Liudmila A Nadtochii, Hifzur R Siddique
Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. Life (Basel, Switzerland) 13 (10) (2023)
Mohammad A Khan, Deepti Singh, Homa Fatma, Kafil Akhtar, Farruk Arjmand, Santosh Maurya, Hifzur R Siddique
Antiandrogen enzalutamide induced genetic, cellular, and hepatic damages: amelioration by triterpene Lupeol. Drug and chemical toxicology (2022)
Santosh Kumar Maurya, Homa Fatma, Akhilesh Kumar Maurya, Nidhi Mishra, Hifzur R Siddique
Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies. In silico pharmacology 10 (1) (2022)
Deepti Singh, Mohammad Afsar Khan, Kafil Akhtar, Sumbul Rehman, Sabiha Parveen, K M Yusuf Amin, Hifzur R Siddique
Protective effects of a polyherbal medicine, Majoon Suranjan against bisphenol-A induced genetic, oxidative and tissue damages. Drug and chemical toxicology (2022)
Homa Fatma, Hifzur R Siddique, Santosh K Maurya
The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers. Epigenomics 13 (23) (2021)
Arsheed A Ganaie, Adrian P Mansini, Tabish Hussain, Arpit Rao, Hifzur R Siddique, Ashraf Shabaneh, Marina G Ferrari, Paari Murugan, Jörg Klingelhöfer, Jinhua Wang, Noona Ambartsumian, Christopher A Warlick, Badrinath R Konety, Mohammad Saleem
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor. Molecular cancer therapeutics 19 (12) (2020)
Santosh K Maurya, Akhilesh Kumar Maurya, Nidhi Mishra, Hifzur R Siddique
Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2. Journal of receptor and signal transduction research 40 (6) (2020)
Deepti Singh, Mohammad Afsar Khan, Hifzur R Siddique
Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting. Molecular biology reports 47 (7) (2020)

Hifzur R Siddique.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hifzur R Siddique